PCN22 COST-EFFECTIVENESS OF SUNITINIBAS SECOND LINE TREATMENT IN PATIENTS WITH METASTATIC RENAL CANCER IN BELGIUM
Nov 1, 2007, 00:00 AM
10.1016/S1098-3015(10)65180-7
https://www.valueinhealthjournal.com/article/S1098-3015(10)65180-7/fulltext
Section Title :
Section Order :
340
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)65180-7&doi=10.1016/S1098-3015(10)65180-7